Securing Your Manufacturing Capacity During the Pandemic

[Available On-Demand]
Search General Info
In this presentation, Richard Lee, Head of DP at Samsung Biologics, talks about the importance of securing secondary source to your pharmaceutical supply chain in a post-Corona era, and how Samsung Biologics is successfully coping with the global pandemic to ensure safety of our employees as well as our client campaigns.

Speaker - Richard Lee, Head of Drug Product Business Unit, Samsung Biologics